7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,754.05

+514.64

+0.67%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

Stockholm - Delayed Quote SEK

Diamyd Medical AB (publ) (DMYD-B.ST)

0.9960 -0.0080 (-0.80%)

At close: October 30 at 12:59:43 PM GMT+1

Diamyd Medical enters into equity financing agreements with new U.S. sector specialist investors for up to USD 125 million and announces full enrollment in Phase 3 trial

PR Newswire 7mo ago

DMYD-B.ST
-0.80%
Diamyd Medical receives Notice of Allowance for key retogatein US patent

PR Newswire 8mo ago

DMYD-B.ST
-0.80%
SE0005162880

DMYDB
Diamyd Medical accelerates primary efficacy readout by 9 months in type 1 diabetes Phase 3 trial following FDA alignment and guidance

PR Newswire 9mo ago

DMYD-B.ST
-0.80%
SE0005162880

DMYD-B
Diamyd Medical announces finalization of database for interim analysis in Phase 3 DIAGNODE-3 trial

PR Newswire 8mo ago

DMYD-B.ST
-0.80%
SE0005162880

DMYDB
European Insider-Owned Growth Stocks For January 2026

Simply Wall St. 8mo ago

OTGLF

DMYD-B.ST
-0.80%
ITAB.ST

Mobilize your Website

View Site in Mobile | Classic

Share by: